Abstract

BackgroundPrimary central nervous system lymphoma (PCNSL), an aggressive type of non-Hodgkin lymphoma, has a poor prognosis. Currently available prognostic scoring systems are inadequate. We therefore aimed to investigate the predictive values of complete blood counts (CBCs) in PCNSL.Materials and MethodsThe cohort of this retrospective study comprised 73 PCNSL patients. The predictive values of selected CBCs, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune inflammation index (SII), and systemic inflammation response index (SIRI), were analyzed.ResultsAges and Memorial Sloan Kettering Cancer Center (MSKCC) scores of PCNSL patients correlated with NLR, PLR, and SII values (p <0.05). Both age and MSKCC scores correlated with inferior progression-free survival (PFS) and overall survival (OS) (p <0.05). High NLR, PLR, SII, and SIRI were significant predictors of shorter PFS and OS (p <0.05). NLR, PLR, SII, and SIRI were integrated to generate a “CBC score” model that accurately stratified PCNSL patients into three risk groups. The median PFS for low-risk, intermediate-risk, and high-risk groups were 24 ((12.458–35.542), 17 (10.626–23.374), and 9 (8.893–19.107) months, respectively (p = 0.011), and the median OS were 33 (19.175–46.825), 18 (16.368–19.632), and 9 (6.521–11.479) months, respectively (p = 0.008). Multivariate Cox regression model showed that MSKCC score (hazard ratio (HR) = 3.791, p <0.001), PLR (HR = 1.003, p = 0.013), and CBC score (HR = 1.873, p = 0.011) were independent predictors for PFS, whereas MSKCC score (HR = 4.128, p <0.001), PLR (HR = 1.003, p = 0.005), and CBC score (HR = 1.907, p = 0.004) were independent predictors for OS.ConclusionThe CBC score model may be a promising predictive system for PCNSL patients.

Highlights

  • Primary central nervous system lymphoma (PCNSL), a rare aggressive extranodal subtype of non-Hodgkin lymphoma, is confined to the central nervous system, including the brain, eyes, spine, and pia mater [1]

  • Ages and Memorial Sloan Kettering Cancer Center (MSKCC) scores of PCNSL patients correlated with neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune inflammation index (SII) values (p

  • Both age and MSKCC scores correlated with inferior progression-free survival (PFS) and overall survival (OS) (p

Read more

Summary

Introduction

Primary central nervous system lymphoma (PCNSL), a rare aggressive extranodal subtype of non-Hodgkin lymphoma, is confined to the central nervous system, including the brain, eyes, spine, and pia mater [1]. PCNSL represents 1–2% of all intracranial neoplasms [2] and 4–6% of all extranodal lymphomas [3]. Since 2000, an increasing incidence of PCNSL has been recognized [4]. Most PCNSLs are diffuse large B cell lymphoma (DLBCL), rare forms include T-cell lymphoma and Burkitt lymphoma. The prognoses of patients with PCNSL are poor, the 5-year survival rate being 33%. Identification of accurate prognostic indicators for PCNSL is urgently required. Primary central nervous system lymphoma (PCNSL), an aggressive type of non-Hodgkin lymphoma, has a poor prognosis. We aimed to investigate the predictive values of complete blood counts (CBCs) in PCNSL

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call